KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Account Payables (2017 - 2025)

Amneal Pharmaceuticals has reported Change in Account Payables over the past 9 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$2.2 million for Q4 2025, down 106.38% from a year ago — trailing twelve months through Dec 2025 was $931000.0 (down 98.29% YoY), and the annual figure for FY2025 was $931000.0, down 98.29%.
  • Change in Account Payables for Q4 2025 was -$2.2 million at Amneal Pharmaceuticals, roughly flat from -$2.2 million in the prior quarter.
  • Over the last five years, Change in Account Payables for AMRX hit a ceiling of $34.1 million in Q4 2024 and a floor of -$7.2 million in Q2 2021.
  • Median Change in Account Payables over the past 5 years was $1.7 million (2021), compared with a mean of $3.2 million.
  • Biggest five-year swings in Change in Account Payables: surged 3526.67% in 2021 and later tumbled 6605.33% in 2022.
  • Amneal Pharmaceuticals' Change in Account Payables stood at $1.6 million in 2021, then tumbled by 124.94% to -$407000.0 in 2022, then soared by 1493.61% to $5.7 million in 2023, then soared by 501.23% to $34.1 million in 2024, then tumbled by 106.38% to -$2.2 million in 2025.
  • The last three reported values for Change in Account Payables were -$2.2 million (Q4 2025), -$2.2 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.